Division of Molecular Biosciences, Faculty of Natural Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
J Biol Chem. 2010 Feb 19;285(8):5759-75. doi: 10.1074/jbc.M109.068353. Epub 2009 Dec 1.
Identifying biological roles for mammalian glycans and the pathways by which they are synthesized has been greatly facilitated by investigations of glycosylation mutants of cultured cell lines and model organisms. Chinese hamster ovary (CHO) glycosylation mutants isolated on the basis of their lectin resistance have been particularly useful for glycosylation engineering of recombinant glycoproteins. To further enhance the application of these mutants, and to obtain insights into the effects of altering one specific glycosyltransferase or glycosylation activity on the overall expression of cellular glycans, an analysis of the N-glycans and major O-glycans of a panel of CHO mutants was performed using glycomic analyses anchored by matrix-assisted laser desorption ionization-time of flight/time of flight mass spectrometry. We report here the complement of the major N-glycans and O-glycans present in nine distinct CHO glycosylation mutants. Parent CHO cells grown in monolayer versus suspension culture had similar profiles of N- and O-GalNAc glycans, although the profiles of glycosylation mutants Lec1, Lec2, Lec3.2.8.1, Lec4, LEC10, LEC11, LEC12, Lec13, and LEC30 were consistent with available genetic and biochemical data. However, the complexity of the range of N-glycans observed was unexpected. Several of the complex N-glycan profiles contained structures of m/z approximately 13,000 representing complex N-glycans with a total of 26 N-acetyllactosamine (Gal beta1-4GlcNAc)(n) units. Importantly, the LEC11, LEC12, and LEC30 CHO mutants exhibited unique complements of fucosylated complex N-glycans terminating in Lewis(x) and sialyl-Lewis(x) determinants. This analysis reveals the larger-than-expected complexity of N-glycans in CHO cell mutants that may be used in a broad variety of functional glycomics studies and for making recombinant glycoproteins.
鉴定哺乳动物糖链的生物学功能及其合成途径,主要得益于对培养细胞系和模式生物糖基化突变体的研究。基于对凝集素抗性的筛选,已成功分离出中国仓鼠卵巢(CHO)糖基化突变体,这对糖基化工程重组糖蛋白具有特别重要的意义。为了进一步提高这些突变体的应用价值,并深入了解改变一个特定糖基转移酶或糖基化活性对细胞糖链整体表达的影响,我们采用糖组学分析方法(以基质辅助激光解吸电离-飞行时间/飞行时间质谱为基础),对 CHO 突变体的 N-糖链和主要 O-糖链进行了分析。在此,我们报告了 9 种不同 CHO 糖基化突变体中主要 N-糖链和 O-糖链的组成。在单层培养和悬浮培养条件下,亲本 CHO 细胞的 N-和 O-GalNAc 糖链谱相似,尽管 Lec1、Lec2、Lec3.2.8.1、Lec4、LEC10、LEC11、LEC12、Lec13 和 Lec30 等突变体的糖链谱与现有的遗传和生化数据一致。然而,观察到的 N-糖链的复杂性却出人意料。几种复杂的 N-糖链谱中含有 m/z 约为 13000 的结构,代表了总共有 26 个 N-乙酰乳糖胺(Galβ1-4GlcNAc)(n)单位的复杂 N-糖链。重要的是,LEC11、LEC12 和 LEC30 CHO 突变体表现出独特的、终止于 Lewis(x)和唾液酸化 Lewis(x)决定簇的岩藻糖基化复杂 N-糖链组成。该分析揭示了 CHO 细胞突变体中 N-糖链的复杂性超出预期,这可能会广泛应用于各种功能糖组学研究和重组糖蛋白的生产。